Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Ranzani

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Health Policy (Amsterdam, Netherlands)|November 15, 2012
Thank you for not smoking: evidence from the Italian smoking banPaolo Buonanno, Marco Ranzani
Genome Biology|September 16, 2014
One patient, two lesions, two oncogenic drivers of gastric cancerClara Alsinet, Marco Ranzani, David J Adams
Pigment Cell & Melanoma Research|January 19, 2017
Synthetic lethality: emerging targets and opportunities in melanomaNicola Thompson, David J Adams, Marco Ranzani
Nature Genetics|August 28, 2014
Cancer gene discovery goes mobileLouise van der Weyden, Marco Ranzani, David J Adams
Molecular Cancer Research : MCR|August 10, 2013
Cancer gene discovery: exploiting insertional mutagenesisMarco Ranzani, Stefano Annunziato, David J Adams, et al.
Archives of Physiotherapy|December 8, 2025
Is resistance training with external loads superior to unloaded exercise in the management of chronic low back pain? A systematic review and meta-analysisMarco Ranzani, Andrea Pozzi, Daniele Fornasari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2014
Lentiviral vector-based insertional mutagenesis identifies genes involved in the resistance to targeted anticancer therapiesMarco Ranzani, Stefano Annunziato, Andrea Calabria, et al.
Wellcome Open Research|May 12, 2017
Revisiting olfactory receptors as putative drivers of cancerMarco Ranzani, Vivek Iyer, Ximena Ibarra-Soria, et al.
The Journal of Pathology|October 11, 2011
Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemiaLeonardo Mirandola, Maurizio Chiriva-Internati, Daniela Montagna, et al.
The Journal of Clinical Investigation|March 25, 2009
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapyEugenio Montini, Daniela Cesana, Manfred Schmidt, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Health Policy (Amsterdam, Netherlands)|November 15, 2012
Thank you for not smoking: evidence from the Italian smoking banPaolo Buonanno, Marco Ranzani
Genome Biology|September 16, 2014
One patient, two lesions, two oncogenic drivers of gastric cancerClara Alsinet, Marco Ranzani, David J Adams
Pigment Cell & Melanoma Research|January 19, 2017
Synthetic lethality: emerging targets and opportunities in melanomaNicola Thompson, David J Adams, Marco Ranzani
Nature Genetics|August 28, 2014
Cancer gene discovery goes mobileLouise van der Weyden, Marco Ranzani, David J Adams
Molecular Cancer Research : MCR|August 10, 2013
Cancer gene discovery: exploiting insertional mutagenesisMarco Ranzani, Stefano Annunziato, David J Adams, et al.
Archives of Physiotherapy|December 8, 2025
Is resistance training with external loads superior to unloaded exercise in the management of chronic low back pain? A systematic review and meta-analysisMarco Ranzani, Andrea Pozzi, Daniele Fornasari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2014
Lentiviral vector-based insertional mutagenesis identifies genes involved in the resistance to targeted anticancer therapiesMarco Ranzani, Stefano Annunziato, Andrea Calabria, et al.
Wellcome Open Research|May 12, 2017
Revisiting olfactory receptors as putative drivers of cancerMarco Ranzani, Vivek Iyer, Ximena Ibarra-Soria, et al.
The Journal of Pathology|October 11, 2011
Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemiaLeonardo Mirandola, Maurizio Chiriva-Internati, Daniela Montagna, et al.
The Journal of Clinical Investigation|March 25, 2009
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapyEugenio Montini, Daniela Cesana, Manfred Schmidt, et al.
Pageof 3